Both in Pharmaceuticals

Amphastar Pharmaceuticals vs Cronos Group Inc. Common Share

Over the past year AMPH returned +6.8% and CRON returned +31.1%; their daily moves had a correlation of 0.04.

AMPH +6.8% CRON +31.1%Growth of $1, one year, split-adjusted
MetricAMPHCRON
Price$27.03$3.33
Market cap$1.15B$1.23B
Today−2.49%+0.91%
1 month+6.3%+3.3%
6 months+18.9%+25.7%
Year to date+0.9%+26.6%
1 year+9.6%+36.5%
Revenue growth (YoY)+5.4%+59.5%
Gross margin50.8%65.8%
Net margin16.5%45.4%
P/E (TTM)14.6×17.5×
Price / sales1.6×4.8×
Net cash-$321.9M$797.0M
Dividend yield——
Volatility (60d)31.3%29.9%
Short % of float14.9%2.1%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).